Agid Y - Search Results

1

[3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy.

Bokobza B, Ruberg M, Scatton B, Javoy-Agid F, Agid Y. Bokobza B, et al. Among authors: agid y. Eur J Pharmacol. 1984 Mar 23;99(2-3):167-75. doi: 10.1016/0014-2999(84)90238-3. Eur J Pharmacol. 1984. PMID: 6734727

2

[3H]spiperone binding in the nigrostriatal system in human brain.

Ruberg M, Bokobza B, Javoy-Agid F, Montfort JC, Agid Y. Ruberg M, et al. Among authors: agid y. Eur J Pharmacol. 1984 Mar 23;99(2-3):159-65. doi: 10.1016/0014-2999(84)90237-1. Eur J Pharmacol. 1984. PMID: 6203765

3

Decrease in [3H]cocaine binding to the dopamine transporter in Parkinson's disease.

Pimoule C, Schoemaker H, Javoy-Agid F, Scatton B, Agid Y, Langer SZ. Pimoule C, et al. Among authors: agid y. Eur J Pharmacol. 1983 Nov 11;95(1-2):145-6. doi: 10.1016/0014-2999(83)90281-9. Eur J Pharmacol. 1983. PMID: 6667712 No abstract available.

4

Binding of [3H]SCH 23390 to D-1 receptors in the putamen of control and parkinsonian subjects.

Raisman R, Cash R, Ruberg M, Javoy-Agid F, Agid Y. Raisman R, et al. Among authors: agid y. Eur J Pharmacol. 1985 Jul 31;113(3):467-8. doi: 10.1016/0014-2999(85)90101-3. Eur J Pharmacol. 1985. PMID: 2864270 No abstract available.

5

D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy.

Pierot L, Desnos C, Blin J, Raisman R, Scherman D, Javoy-Agid F, Ruberg M, Agid Y. Pierot L, et al. Among authors: agid y. J Neurol Sci. 1988 Sep;86(2-3):291-306. doi: 10.1016/0022-510x(88)90106-2. J Neurol Sci. 1988. PMID: 2975699

6

Pathophysiology of L-dopa-induced abnormal involuntary movements.

Agid Y, Bonnet AM, Ruberg M, Javoy-Agid F. Agid Y, et al. Psychopharmacology Suppl. 1985;2:145-59. doi: 10.1007/978-3-642-70140-5_19. Psychopharmacology Suppl. 1985. PMID: 2987904

7

[3H]GBR 12935 binding to dopamine uptake sites: subcellular localization and reduction in Parkinson's disease and progressive supranuclear palsy.

Maloteaux JM, Vanisberg MA, Laterre C, Javoy-Agid F, Agid Y, Laduron PM. Maloteaux JM, et al. Among authors: agid y. Eur J Pharmacol. 1988 Nov 8;156(3):331-40. doi: 10.1016/0014-2999(88)90278-6. Eur J Pharmacol. 1988. PMID: 3215281

8

[Dementia and Parkinson's disease: biochemical and anatomo-clinical correlation].

Dubois B, Hauw JJ, Ruberg M, Serdaru M, Javoy-Agid F, Agid Y. Dubois B, et al. Among authors: agid y. Rev Neurol (Paris). 1985;141(3):184-93. Rev Neurol (Paris). 1985. PMID: 4001706 French.

9

Somatostatin and dementia in Parkinson's disease.

Epelbaum J, Ruberg M, Moyse E, Javoy-Agid F, Dubois B, Agid Y. Epelbaum J, et al. Among authors: agid y. Brain Res. 1983 Nov 14;278(1-2):376-9. doi: 10.1016/0006-8993(83)90277-9. Brain Res. 1983. PMID: 6139152

10

[3H]imipramine binding in subcellular fractions of rat cerebral cortex after chemical lesion of serotonergic neurons.

Sette M, Ruberg M, Raisman R, Scatton B, Zivkovic B, Agid Y, Langer SZ. Sette M, et al. Among authors: agid y. Eur J Pharmacol. 1983 Nov 11;95(1-2):41-51. doi: 10.1016/0014-2999(83)90265-0. Eur J Pharmacol. 1983. PMID: 6199218

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

759 results

Search Page

Filters